Key result
Metabolic syndrome and elevated blood pressure accelerate arterial stiffness in youth with type 1 diabetes.
Why the study?
Do cardiovascular risk factors and metabolic syndrome accelerate the progression of arterial stiffness in youth with type 1 diabetes?
Cohort (n=298)
Yes
Do cardiovascular risk factors and metabolic syndrome accelerate the progression of arterial stiffness in youth with type 1 diabetes?
p-value: p=<0.0001
In youth with type 1 diabetes, the presence and worsening of cardiovascular risk factors, particularly central adiposity and elevated blood pressure, are associated with increased arterial stiffness over time.
Metabolic syndrome and related factors may accelerate arterial stiffening in youth with type 1 diabetes; hypothesis-generating for targeted interventions.
OBJECTIVE: To evaluate if presence of cardiovascular (CV) risk factors and their clustering as metabolic syndrome (MetS) is associated with increased arterial stiffness and accelerated progression over time among youth with type 1 diabetes. RESEARCH DESIGN AND METHODS: Longitudinal study of 298 youth with type 1 diabetes (age 14.5 years; 46.3% female; duration 4.8 years), with two research visits conducted 5 years apart. CV factors included: waist circumference, blood pressure (BP), fasting lipids (HDL cholesterol, LDL cholesterol [LDL-c], triglycerides), albumin/creatinine ratio, and HbA1c. MetS was based on Adult Treatment Panel III criteria modified for youth. Pulse wave velocity (PWV) in the carotid-femoral segment was measured by tonometry. Mixed models were used to assess the rate of progression in PWV and the association between CV factors and PWV over time. RESULTS: PWV increased significantly over time (0.145 m/s/year; P < 0.0001). MetS (P = 0.0035), large waist (P < 0.0001), and elevated BP (P = 0.0003) at baseline were each associated with worse PWV over time. These baseline factors, however, did not significantly influence the rate of progression. Increases in waist circumference (P < 0.0001), LDL-c levels (P = 0.0156), and declining glucose control (HbA1c; P = 0.0419) were independently associated with higher PWV over time. CONCLUSIONS: Presence, clustering, and worsening of CV risk factors are associated with increased arterial stiffness over time in youth with type 1 diabetes. Whether improvement in CV risk factors early in life will slow the progression of arterial stiffness and reduce the burden of CV disease in this population requires further study.
No takes yet. Share an insight, caveat, or question.
Dabelea et al. (2013) conducted a cohort in Type 1 diabetes (n=298). Cardiovascular risk factors (Metabolic syndrome, large waist circumference, elevated blood pressure) vs. Absence of or lower levels of cardiovascular risk factors was evaluated on Progression of arterial stiffness measured by pulse wave velocity (PWV) over time (p=<0.0001). In youth with type 1 diabetes, pulse wave velocity increased significantly by 0.145 m/s/year over 5 years, and baseline metabolic syndrome, large waist, and elevated blood pressure were associated with higher arterial stiffness.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: